 Drug price sensitivity among physicians in a developing healthcare system: Evidence from the Philippine market for statins and beta blockersCielo Magno and Ricardo Rafael S. Guzman Economic Analysis and Policy, 2019, vol. 62, issue C, 268-279 Abstract: In healthcare systems with limited drug regulation and weakly enforced generic substitution policies, do physicians prescribe drugs on the basis of prices? This paper tests this result by examining prescription behavior in the Philippines market for lipid-lowering and cardioselective beta blocking agents. Using individual level data on physician prescriptions from the 2013 IMS Health Physician Medical Data Index, we estimate a nested multinomial logit model to examine responses of physicians to price variations across and within an expanded choice set of generic, branded originator, and branded non-originator (‘me-too’) drugs. We demonstrate that price variation across molecules has a substantial effect on the choice of molecule and this effect varies with physician and patient characteristics. This suggests price sensitivity on the part of the physicians who may adjust their prescriptions accordingly. Keywords: Prescription drugs; Physician prescribing behavior; Price-sensitivity; Generic drugs; Branded drugs (search for similar items in EconPapers) Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:eee:ecanpo:v:62:y:2019:i:c:p:268-279 DOI: 10.1016/j.eap.2019.04.005 Access Statistics for this article Economic Analysis and Policy is currently edited by Clevo Wilson More articles in Economic Analysis and Policy from Elsevier |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.